This discussion has been published as a research paper
TDX-2026-00020
IV thrombolysis in wake-up stroke with DWI-FLAIR mismatch: evidence for extending the treatment window?
67F found unresponsive with left hemiplegia at 06:00, last known well at 22:00 (8-hour window). NIHSS 14. CT showed no hemorrhage. MRI (door-to-MRI 28 minutes):
- DWI: acute right MCA territory infarct involving insula and frontal operculum (volume ~18 mL)
- FLAIR: no corresponding hyperintensity (positive DWI-FLAIR mismatch)
- MRA: right M1 occlusion with good collaterals
CTP:
- Core: 15 mL
- Penumbra: 85 mL (Tmax > 6s)
- Mismatch ratio: 5.7
The WAKE-UP trial showed benefit of IV alteplase in DWI-FLAIR mismatch patients. But this patient also qualifies for mechanical thrombectomy based on DAWN/DEFUSE 3 imaging criteria.
Questions:
- Do you give IV alteplase before thrombectomy in this scenario, or proceed directly to thrombectomy?
- If giving alteplase, do you use the full 0.9 mg/kg dose or a reduced dose (as is common practice in Japan at 0.6 mg/kg)?
- How do you interpret the absence of FLAIR changes at 8 hours: does this truly indicate < 4.5 hours from onset, or could it represent slow diffusion in well-collateralized territory?
2 Answers
Excellent case that highlights the evolving paradigm in stroke treatment. My approach at NIMHANS:
1. IV alteplase before thrombectomy: Yes, I give IV thrombolysis before thrombectomy in this scenario. The rationale:
- WAKE-UP trial specifically validated DWI-FLAIR mismatch for IV thrombolysis decision-making
- The "drip and ship" model showed no harm from bridging IV tPA in the SWIFT DIRECT and DIRECT-MT trials (though these tested known-onset strokes)
- IV alteplase may lyse distal clot fragments and improve microvascular reperfusion even if the M1 occlusion requires mechanical intervention
- Do not delay thrombectomy for alteplase completion. Start the infusion and proceed to angiography simultaneously.
2. Dosing: I use the standard 0.9 mg/kg (10% bolus, 90% infusion over 1 hour). I am aware of the J-MARS and ENCHANTED data supporting 0.6 mg/kg in Asian populations, but the ENCHANTED trial showed a trend toward inferior outcomes with low-dose tPA in large vessel occlusion specifically. For an M1 occlusion, I want maximum thrombolytic effect.
3. DWI-FLAIR mismatch interpretation: The absence of FLAIR signal at 8 hours from LKW is most likely because the true onset is more recent (probably 3-5 hours). FLAIR hyperintensity typically appears within 4-6 hours of stroke onset. However, you are correct that excellent collaterals can delay FLAIR changes. The CTP data here is reassuring: 15 mL core with 85 mL penumbra and mismatch ratio 5.7 confirms substantial salvageable tissue regardless of exact onset time.
Bottom line for this patient: IV alteplase 0.9 mg/kg + immediate thrombectomy. The imaging profile is ideal.